Jiangsu Hengrui Medicine Co., Ltd. (600276.SS) SHH

Currency In CNY

AD

Valuation

Market Cap387.22B
Enterprise Value347.2B
P/E Ratio40.01
PEG Ratio2.54
Price/Sales Ratio9.8
Price/Book Ratio5.19
Enterprise/Revenue8.55
Enterprise/EBITDA28.75

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin0.25
Operating Margin0.28
AD

Management Effectiveness

Return On Assets0.11
Return On Equity0.13

Income Statement

Revenue31.43B
Revenue/Share4.94
Gross Profit26.67B
EBITDA9.67B
Net Income7.71B
Diluted EPS1.18

Balance Sheet

Total Cash40.64B
Total Cash/Share6.16
Total Debt67.47M
Total Debt/Equity0
Current Ratio9.23
Book Value Per Share9.72

Price History

52-Week Change-3.75
52-Week High74.04
52-Week Low45.26
Moving Average 50 Days51.9
Moving Average 200 Days59.03

Statistics

Average Volume76.57M
Shares Outstanding6.38B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.2
Trailing Annual Dividend Yield0.4
Payout Ratio0.16
Last Split Factor6:5
Last Split DateJune 10, 2021
AD